Home
Conditions
Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity

Clinical trial condition

Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity

Explore clinical trials studying Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity. Study availability and eligibility vary by location and protocol.

28 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity trial results

Completed

Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

NCT00114283

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +46 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck

NCT01334177

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +53 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00507767

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +48 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

NCT00387335

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +19 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

NCT00101348

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +122 more
Locations: Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States

View Trial Details

Completed

Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT00103259

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +35 more
Locations: Eastern Cooperative Oncology Group Boston, Massachusetts, United States

View Trial Details

Completed

Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer

NCT00492089

Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Meningioma, +126 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00513435

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

NCT00098631

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +21 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer

NCT00055770

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +32 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity

Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity trial results

Related conditions